Lymphoma & Plasma Cell Disorders
Conference Coverage
No SPARKLE with ibrutinib plus chemo in r/r pediatric B-NHL
Clinical Insights
The power and promise of social media in oncology
Dr. Alan Lyss describes a recent presentation on the role of social media in oncology.
From the Journals
Hyperprogression on immunotherapy: When outcomes are much worse
News
FDA approves loncastuximab for diffuse large B-cell lymphomas
From the Journals
Frontline brentuximab vedotin shows promise in high-risk pediatric Hodgkin lymphoma
Conference Coverage
Personalized cancer vaccine shows early promise across tumor types
The vaccine consists of patient-specific synthetic neoantigen peptides and is given to patients in the adjuvant setting.
From the Journals
Evidence favors lower-dose R-CHOP for fit, very elderly DLBCL patients
Conference Coverage
Combo provides ‘broad benefit’ across NHL subtypes
Adding copanlisib to rituximab improved progression-free survival, but overall survival data are not mature.
Clinical Insights
Steroid-refractory pneumonitis from ICIs: Experience at major centers
Feature
Cancer screening stopped by pandemic: Repercussions to come?
From the Journals
Steroids can be stopped in some older multiple myeloma patients